scispace - formally typeset
L

Lalit Kumar

Researcher at Central Drug Research Institute

Publications -  91
Citations -  970

Lalit Kumar is an academic researcher from Central Drug Research Institute. The author has contributed to research in topics: AC power & Computer science. The author has an hindex of 15, co-authored 75 publications receiving 778 citations.

Papers
More filters
Journal ArticleDOI

Circular RNAs: the Emerging Class of Non-coding RNAs and Their Potential Role in Human Neurodegenerative Diseases

TL;DR: The possibility of exploring the role of circRNAs in the context of the central nervous system (CNS) and age-associated neurodegenerative diseases is reviewed.
Journal ArticleDOI

Functional Characterization of Novel Circular RNA Molecule, circzip-2 and Its Synthesizing Gene zip-2 in C. elegans Model of Parkinson’s Disease

TL;DR: Employing transgenic C. elegans model of PD, RNase R-mediated cleavage of linear RNA followed by divergent primer-based amplifications are used towards identifying circzip-2, a novel circRNA molecule, which is synthesized from functionally important gene zip-2.
Journal ArticleDOI

A dual colorimetric-ratiometric fluorescent probe NAP-3 for selective detection and imaging of endogenous labile iron(III) pools in C. elegans.

TL;DR: The first dual colorimetric and ratiometric fluorescent probe naphtho[2,1-b][1,10]phenanthroline for selective and 'direct' visualization of labile iron(III) pools in a multicellular organism, Caenorhabditis elegans is reported.
Journal ArticleDOI

Imidazole derivatives as possible microbicides with dual protection.

TL;DR: It is concluded that introduction of the pharmacophore responsible for spermicidal activity into a proven anti-trichomonas structure may lead to a potent dual function microbicide better and safer than N-9.
Journal ArticleDOI

Carbodithioic acid esters of fluoxetine, a novel class of dual-function spermicides ☆

TL;DR: The study revealed that incorporation of carbodithioic acid residue directly into fluoxetine structure leads to compounds with better antifungal and anti-Trichomonas activities, and N-methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]carbodithIOic acid S-(2-pyrrolidino-ethyl) ester (14) has shown better profile than both fluoxettine